Herold Advisors’s Danimer Scientific, Inc. DNMR Stock Holding History

Herold Advisors’s Portfolio DNMR Stock Details DNMR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-13	Closed	-$2.93K	–	703
2022 Q1	$2.93K	Buy	+13	New	+$2.63K	﹤0.01%	695
2021 Q4	–	Sell	-16	Closed	-$10K	–	678
2021 Q3	$10K	Buy	+16	New	+$11.8K	﹤0.01%	600

Other funds holding DNMR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAN

Integrated Advisors Network Dallas, Texas $1.91B AUM 24.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

CIA

Capital Investment Advisors Atlanta, Georgia $6.84B AUM 17.28% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Herold Advisors's DNMR Position: Q2 2022 in Review

Herold Advisors sold out of Danimer Scientific, Inc. (DNMR) in Q2 2022, closing a stake of 13 shares — an estimated $2.93K sold.

Herold Advisors first reported a position in DNMR in Q3 2021 and held it in 2 quarters. The position peaked at $10K in Q3 2021. 192 funds tracked by Wall St. Rank hold DNMR as of Q2 2022.

Herold Advisors reported no remaining Danimer Scientific, Inc. position as of Q2 2022 after selling out during the quarter.
Herold Advisors sold 13 Danimer Scientific, Inc. shares in Q2 2022, an estimated $2.93K.
Herold Advisors first reported a position in Danimer Scientific, Inc. in Q3 2021 and held it in 2 quarters.
Herold Advisors's Danimer Scientific, Inc. position peaked at $10K in Q3 2021.
192 funds tracked by Wall St. Rank held Danimer Scientific, Inc. as of Q2 2022.

Based on Herold Advisors's 13F filing for Q2 2022, filed 15 Jul 2022.